Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod

Imiquimod is a topical toll-like-receptor-7 agonist currently used for treating basal cell carcinoma. Recently, imiquimod has demonstrated tumor regression in melanoma and breast cancer skin metastases. However, the molecular perturbations induced by imiquimod in breast cancer metastases have not be...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozenblit, Mariya, Hendrickx, Wouter, Heguy, Adriana, Chiriboga, Luis, Loomis, Cynthia, Ray, Karina, Darvishian, Farbod, Egeblad, Mikala, Demaria, Sandra, Marincola, Francesco M., Bedognetti, Davide, Adams, Sylvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561945/
https://www.ncbi.nlm.nih.gov/pubmed/31189943
http://dx.doi.org/10.1038/s41598-019-42784-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561945/
https://www.ncbi.nlm.nih.gov/pubmed/31189943
http://dx.doi.org/10.1038/s41598-019-42784-9

Ejemplares similares